{
  "symbol": "AMGN",
  "year": 2022,
  "period": "Y2022",
  "competition_summary": [
    {
      "competitor": "Celgene Celgene Corporation CGRP",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "CHMP Committee for Medicinal Products for Human",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "CIT",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "CMS Centers for",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "CV",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "DaVita DaVita Inc.",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "EC European Commission",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "EMA European Medicines Agency",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "EPS",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "ERG",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "ESA",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "ESG",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "ESRD",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "EU European Union FASB Financial Accounting Standards Board",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "FDA U.S. Food and Drug Administration FDCA Federal Food, Drug",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "Cosmetic Act FGFR2b",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "Fitch Fitch Ratings, Inc. ii",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "Management Board",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "Puerto Rico FTC Federal Trade Commission",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    },
    {
      "competitor": "GDPR General Data Protection",
      "mentions": 1,
      "context": "Competition and Innovation Act of 2009 Celgene Celgene Corporation CGRP calcitonin gene-related peptide chemotherapy anticancer medicines CHMP Committee for Medicinal Products for Human Use CIT chemotherapy-induced thrombocytopenia CKD chronic kidney disease CMS Centers for Medicare & Medicaid Services COSO Committee of Sponsoring Organizations of the Treadway Commission COVID-19 coronavirus disease 2019 CV cardiovascular DaVita DaVita Inc. DLL3 delta-like ligand 3 DOJ U.S. Department of Justice"
    }
  ]
}